<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00771485</url>
  </required_header>
  <id_info>
    <org_study_id>PL08.01</org_study_id>
    <nct_id>NCT00771485</nct_id>
  </id_info>
  <brief_title>Study of Efficacy of Bowel Preparation Before Colonoscopy</brief_title>
  <official_title>Study of Efficacy of Bowel Preparation Before Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>C.B. Fleet Company, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>C.B. Fleet Company, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of FM-602 as a bowel preparation
      before colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of bowel cleansing assessed by the examining physician</measure>
    <time_frame>During colonoscopy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">148</enrollment>
  <condition>Bowel Cleansing Prior to Colonoscopy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FM-602</intervention_name>
    <description>Study of Efficacy of Bowel Preparation Before Colonoscopy</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marketed Bowel Cleanser</intervention_name>
    <description>Marketed bowel cleanser</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are men or nonpregnant women who are scheduled for an elective colonoscopy and who are
             at least 18 years of age,

          -  Are, in the opinion of the Investigator, able to communicate with study personnel and
             comply with the requirements of the study,

          -  Are able and willing to follow the study-specified testing including the diet and
             hydration regimen, and

          -  Have been informed of the nature and risks of the study and have given written
             informed consent at Screening and before any study-related tests are done.

        Exclusion Criteria:

          -  Have any known contraindications to the study procedures or treatment,

          -  Have clinically significant active cardiovascular disease, including a history of
             myocardial infarction, within the past 6 months and/or heart failure

          -  Have known or suspected electrolyte abnormalities, gastrointestinal obstruction,
             gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus,

          -  Have any history of prior colon surgery,

          -  History of active inflammatory bowel disease,

          -  Have clinical evidence of dehydration,

          -  Are pregnant or breast-feeding,

          -  Are unwilling to abstain from alcohol consumption from the day before colonoscopy
             until discharged from the study,

          -  Are unwilling to use any prohibited medications, including laxatives, 4 days before
             receiving the first study dose,

          -  Have received any investigational agent within 30 days before dosing,

          -  Have any known or suspected allergies, sensitivity or an unwillingness to consume
             components of the study medication,

          -  Known or suspected phenylketonuria (PKU) or sensitivity to products containing
             phenylalanine, or is on a phenylalanine-reduced diet,

          -  A history of hemolysis or taking concomitant medications known to precipitate
             hemolytic reactions,

          -  Have any other condition which in the Investigator's opinion would make the subject
             unsuitable for inclusion into the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sherrie McNamara, RN, MSN, MBA</last_name>
    <role>Study Director</role>
    <affiliation>C.B. Fleet Company, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Advanced Clinical Research Institute</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cumberland Research Associates, LLC</name>
      <address>
        <city>Fayetteville</city>
        <state>North Carolina</state>
        <zip>28304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Associates of Tidewater</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2008</study_first_submitted>
  <study_first_submitted_qc>October 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2008</study_first_posted>
  <last_update_submitted>February 8, 2012</last_update_submitted>
  <last_update_submitted_qc>February 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

